456 Studies Now Enrolling
REWARDS Premier TLX- Multicenter, retrospective registry to collect baseline, clinical, procedural, in hospital and 9-12 month follow-up data to compare major adverse cardiac events in patients receiving Promus Premier drug eluting stent to data already collected from the REWARDS-TLX Registry in which patients received either the Taxus Liberte or XIENCE V drug eluting stent
A follow-up survey for patients with Coronary artery disease who have received the Promus Premier drug eluting stent
| Sponsor: | Medstar Research Institute |
| Enrolling: | Male and Female Patients |
| IRB Number: | AAAO5155 |
| U.S. Govt. ID: | NCT02256527 |
| Contact: | Tamim Nazif: 212-305-7060 / tmn31@columbia.edu |
Additional Study Information:
The purpose of this study is to survey patients who have undergone a percutaneous coronary intervention (PCI) at Columbia University Medical Center in which the physician used a stent called the Promus Premier stent. Patients will be asked to do a brief 15-30 minute survey regarding their health since the PCI and stent implantation.
This study is closed
